Annual report
7915.TEDINET S100T30E
Period2023-01-01 → 2023-12-31
Filed2024-03-22
StandardIFRS
ConsolidatedYes
Data checks19 of 19 passed
Key figures · 164
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥167.7bn | 2023-01-01 → 2023-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥194.0bn | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥189.3bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales IFRS (5-year summary) |
| Revenue | ¥180.0bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales IFRS (5-year summary) |
| Revenue | ¥173.2bn | 2019-01-01 → 2019-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥174.0bn | 2019-01-01 → 2019-12-31d | Cons. | Net sales IFRS (5-year summary) |
| Operating income | −¥3.8bn | 2023-01-01 → 2023-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥9.5bn | 2022-01-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Ordinary income | −¥4.7bn | 2019-01-01 → 2019-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥2.8bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥12.4bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥19.5bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥7.0bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | −¥16.6bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | −¥3.0bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥10.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥15.9bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥7.1bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | −¥4.1bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥17.2bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | −¥3.0bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥10.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Total assets | ¥217.9bn | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥230.2bn | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥209.3bn | at 2021-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥199.6bn | at 2020-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥190.6bn | at 2019-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥186.8bn | at 2019-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥107.0bn | at 2023-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥118.7bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥110.9bn | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥111.5bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥98.3bn | at 2021-12-31d | Cons. | Equity IFRS |
| Net assets / equity | ¥86.3bn | at 2019-12-31d | Cons. | Net assets (5-year summary) |
| Equity (owners) | ¥110.9bn | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥111.6bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥98.3bn | at 2021-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥81.9bn | at 2020-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥75.0bn | at 2019-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥37.9bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥54.3bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥42.3bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥25.1bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥17.5bn | at 2019-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥12.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥18.8bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥14.6bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥164m | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.6bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥8.0bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥4.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥6.9bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥1.4bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥4.9bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.9bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥12.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥1.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥2.6bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥6.0bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥5.1bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.7bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥-61.13 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥203.65 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥318.35 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥141.34 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥-82.77 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-344.27 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥317.16 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥137.78 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥-344.27 | 2019-01-01 → 2019-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥2,281.64 | at 2023-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥2,257.47 | at 2022-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,972.89 | at 2021-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,638.46 | at 2020-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,728.26 | at 2019-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,502.74 | at 2019-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 50.9% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 48.5% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 47.0% | at 2021-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 41.1% | at 2020-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 45.3% | at 2019-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.2% | at 2019-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | -2.7% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 9.7% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 17.6% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 9.0% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -4.7% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | -20.6% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 5,221 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 5,325 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 5,409 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 5,390 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 5,718 | at 2019-12-31d | Cons. | Number of employees |
| Revenue | ¥68.9bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥93.5bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥113.0bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥115.7bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥108.2bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥3.4bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Operating income | ¥1.5bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Ordinary income | ¥1.8bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥9.9bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥6.9bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥437m | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥4.9bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥11.9bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Net income | −¥4.5bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥10.8bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥6.2bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥5.5bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥1.3bn | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥142.9bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥159.2bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥150.3bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥154.0bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥150.0bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥58.8bn | at 2023-12-31 | Standalone | Liabilities |
| Total liabilities | ¥68.4bn | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥84.1bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥90.7bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥85.3bn | at 2021-12-31d | Standalone | Net assets |
| Net assets / equity | ¥81.5bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥79.2bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥15.2bn | at 2023-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥43.0bn | at 2022-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-91.35 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥217.18 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥124.85 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.97 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-25.23 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥124.38 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥108.17 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥50 | 2023-01-01 → 2023-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥35 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,729.67 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,836.15 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,711.67 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,629.17 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,587.25 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 58.8% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.0% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.7% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.9% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.8% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -5.1% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.3% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.5% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | -1.6% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 50,855,000 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,855,000 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,855,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,855,000 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,855,000 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 720 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 710 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 731 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 720 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 819 | at 2019-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-12-31 | ¥9.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-12-31 | ¥10.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-12-31 | −¥860m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-12-31 | −¥1.2bn |
| Reconciling Itemsreconciling | segment assets | at 2023-12-31 | ¥67.8bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | −¥3.0bn |
| Devicesreportable segment | employees | at 2023-12-31 | 912 pure |
| Devicesreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥54.9bn |
| Devicesreportable segment | segment assets | at 2023-12-31 | ¥34.4bn |
| Devicesreportable segment | segment profit | 2023-01-01 → 2023-12-31 | −¥1.6bn |
| Industrial Materialsreportable segment | employees | at 2023-12-31 | 2461 pure |
| Industrial Materialsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥69.0bn |
| Industrial Materialsreportable segment | segment assets | at 2023-12-31 | ¥54.7bn |
| Industrial Materialsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥93m |
| Medical Technologiesreportable segment | employees | at 2023-12-31 | 1263 pure |
| Medical Technologiesreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥36.0bn |
| Medical Technologiesreportable segment | segment assets | at 2023-12-31 | ¥50.3bn |
| Medical Technologiesreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥1.5bn |
| Other And Corporate R And D Administrativereportable segment | employees | at 2023-12-31 | 585 pure |
| —segment total | revenue | 2023-01-01 → 2023-12-31 | ¥159.8bn |
| —segment total | segment assets | at 2023-12-31 | ¥139.4bn |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | ¥6m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-12-31 | ¥168.9bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-12-31 | ¥150.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-12-31 | −¥853m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-12-31 | ¥9.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-12-31 | ¥10.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-12-31 | −¥759m |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-12-31 | −¥1.3bn |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥80.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥1.9bn |
| Devicesreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥80.0bn |
| Devicesreportable segment | segment assets | at 2022-12-31 | ¥35.9bn |
| Devicesreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥8.3bn |
| Industrial Materialsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥73.8bn |
| Industrial Materialsreportable segment | segment assets | at 2022-12-31 | ¥56.8bn |
| Industrial Materialsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥3.4bn |
| Medical Technologiesreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥32.5bn |
| Medical Technologiesreportable segment | segment assets | at 2022-12-31 | ¥47.2bn |
| Medical Technologiesreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥490m |
| —segment total | revenue | 2022-01-01 → 2022-12-31 | ¥186.2bn |
| —segment total | segment assets | at 2022-12-31 | ¥139.8bn |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | ¥12.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-12-31 | ¥195.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-12-31 | ¥150.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-12-31 | ¥11.4bn |
| Devicesreportable segment | employees | at 2023-12-31 | 198 pure |
| Industrial Materialsreportable segment | employees | at 2023-12-31 | 199 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,075
| Item | Context | Value | Unit |
|---|---|---|---|
| Retained earnings IFRS | Prior1YearInstant | 75658000000 | JPY |
| Retained earnings IFRS | CurrentYearInstant | 69934000000 | JPY |
| Treasury shares IFRS | Prior1YearInstant | -2632000000 | JPY |
| Treasury shares IFRS | CurrentYearInstant | -4019000000 | JPY |
| Other components of equity IFRS | Prior1YearInstant | 11565000000 | JPY |
| Other components of equity IFRS | CurrentYearInstant | 18013000000 | JPY |
| Equity attributable to owners of parent IFRS | Prior1YearInstant | 111553000000 | JPY |
| Equity attributable to owners of parent IFRS | CurrentYearInstant | 110913000000 | JPY |
| Non controlling interests IFRS | Prior1YearInstant | -34000000 | JPY |
| Non controlling interests IFRS | CurrentYearInstant | -60000000 | JPY |
| Equity IFRS | Prior1YearInstant | 111518000000 | JPY |
| Equity IFRS | CurrentYearInstant | 110852000000 | JPY |
| Liabilities and equity IFRS | Prior1YearInstant | 230212000000 | JPY |
| Liabilities and equity IFRS | CurrentYearInstant | 217853000000 | JPY |
| Net sales IFRS | Prior1YearDuration | 193963000000 | JPY |
| Net sales IFRS | CurrentYearDuration | 167726000000 | JPY |
| Cost of sales IFRS | Prior1YearDuration | 151540000000 | JPY |
| Cost of sales IFRS | CurrentYearDuration | 135103000000 | JPY |
| Gross profit IFRS | Prior1YearDuration | 42422000000 | JPY |
| Gross profit IFRS | CurrentYearDuration | 32622000000 | JPY |
| Selling general and administrative expenses IFRS | Prior1YearDuration | 31147000000 | JPY |
| Selling general and administrative expenses IFRS | CurrentYearDuration | 33000000000 | JPY |
| Other income IFRS | Prior1YearDuration | 949000000 | JPY |
| Other income IFRS | CurrentYearDuration | 698000000 | JPY |
| Other expenses IFRS | Prior1YearDuration | 2646000000 | JPY |
| Other expenses IFRS | CurrentYearDuration | 3894000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | Prior1YearDuration | -57000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYearDuration | -243000000 | JPY |
| Operating profit loss IFRS | Prior1YearDuration | 9520000000 | JPY |
| Operating profit loss IFRS | CurrentYearDuration | -3817000000 | JPY |
| Finance income IFRS | Prior1YearDuration | 3768000000 | JPY |
| Finance income IFRS | CurrentYearDuration | 2897000000 | JPY |
| Finance costs IFRS | Prior1YearDuration | 916000000 | JPY |
| Finance costs IFRS | CurrentYearDuration | 1842000000 | JPY |
| Profit loss before tax IFRS | Prior1YearDuration | 12373000000 | JPY |
| Profit loss before tax IFRS | CurrentYearDuration | -2762000000 | JPY |
| Income tax expense IFRS | Prior1YearDuration | 2253000000 | JPY |
| Income tax expense IFRS | CurrentYearDuration | 252000000 | JPY |
| Profit loss IFRS | Prior1YearDuration | 10119000000 | JPY |
| Profit loss IFRS | CurrentYearDuration | -3014000000 | JPY |
| Profit loss attributable to owners of parent IFRS | Prior1YearDuration | 10140000000 | JPY |
| Profit loss attributable to owners of parent IFRS | CurrentYearDuration | -2988000000 | JPY |
| Profit loss attributable to non controlling interests IFRS | Prior1YearDuration | 21000000 | JPY |
| Profit loss attributable to non controlling interests IFRS | CurrentYearDuration | 25000000 | JPY |
| Profit loss IFRS | Prior1YearDuration | 10119000000 | JPY |
| Profit loss IFRS | CurrentYearDuration | -3014000000 | JPY |
| Basic earnings loss per share IFRS | Prior1YearDuration | 203.65 | |
| Basic earnings loss per share IFRS | CurrentYearDuration | -61.13 | |
| Diluted earnings loss per share IFRS | Prior1YearDuration | － | |
| Diluted earnings loss per share IFRS | CurrentYearDuration | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 19 of 19 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |